Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Accumulated Expenses (2018 - 2025)

TransMedics (TMDX) has 8 years of Accumulated Expenses data on record, last reported at $28.4 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 26.28% year-over-year to $28.4 million; the TTM value through Dec 2025 reached $28.4 million, up 26.28%, while the annual FY2025 figure was $28.4 million, 26.28% up from the prior year.
  • Accumulated Expenses reached $28.4 million in Q4 2025 per TMDX's latest filing, down from $56.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $56.0 million in Q3 2025 and bottomed at $3.3 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $22.1 million, with a median of $17.5 million recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: crashed 66.5% in 2021, then surged 288.06% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $16.3 million in 2021, then increased by 14.07% to $18.6 million in 2022, then surged by 105.1% to $38.2 million in 2023, then crashed by 41.07% to $22.5 million in 2024, then grew by 26.28% to $28.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $28.4 million in Q4 2025, $56.0 million in Q3 2025, and $42.5 million in Q2 2025.